Fundraising FoxSigrid Therapeutics
4 known investors
Find your way into Sigrid Therapeutics
Sign up to see every warm intro you have to Sigrid Therapeutics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Sigrid Therapeutics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Sigrid Therapeutics develops non-pharmaceutical solutions for blood sugar control and weight management using its patented SiPore silica technology, which slows the digestion of carbohydrates and fats in the gut. The company offers medical and consumer metabolic health products aimed at people with prediabetes, diabetes, and obesity.
Founders & leadership
SA
Sana AlajmovicCo-founder & CEO
Investors · 4
Joyance Partnerslisted by Joyance PartnersBerlin
How we know: newswire.ca · joyancepartners.com · Not right? Tell us
Ataraxia VCreportedSan Francisco · $50K – $1M
How we know: a partner's Signal profile · Not right? Tell us
Also in the syndicate · 2
Crosslight PartnersIrrus Investments
In the news
Frequently asked questions
- What does Sigrid Therapeutics do?
- Sigrid Therapeutics develops non-pharmaceutical solutions for blood sugar control and weight management using its patented SiPore silica technology, which slows the digestion of carbohydrates and fats in the gut. The company offers medical and consumer metabolic health products aimed at people with prediabetes, diabetes, and obesity.
- Who founded Sigrid Therapeutics?
- Sigrid Therapeutics was founded by Sana Alajmovic.
- Who are Sigrid Therapeutics's investors?
- Sigrid Therapeutics's investors include Joyance Partners, Ataraxia VC.